Results 181 to 190 of about 231,717 (193)
Some of the next articles are maybe not open access.

Editorial Commentary: Advances in transthyretin amyloid cardiomyopathy

Trends in Cardiovascular Medicine, 2021
Merrill D, Benson, Noel R, Dasgupta
openaire   +2 more sources

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy

JACC: CardioOncology, 2021
Sarah A M Cuddy   +2 more
exaly  

Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy

Journal of Cardiology, 2022
Kenichi Matsushita   +2 more
exaly  

Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges

Journal of Clinical Medicine, 2022
Carsten Tschöpe, Ahmed Elsanhoury
exaly  

Inotersen therapy of transthyretin amyloid cardiomyopathy

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2020
Merrill D Benson, Jessica Smith
exaly  

Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy

European Heart Journal Cardiovascular Imaging, 2022
Christina Binder   +2 more
exaly  

Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2017
Merrill D Benson   +2 more
exaly  

Transthyretin Gene Silencing in Amyloid Transthyretin Cardiomyopathy

Journal of the American College of Cardiology
Amrut V. Ambardekar, Sarah A.M. Cuddy
openaire   +1 more source

Home - About - Disclaimer - Privacy